CTOs on the Move

MPI Research

www.mpiresearch.com

 
MPI Research, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. MPI Research, Inc. is based in Mattawan, MI. You can find more information on MPI Research, Inc. at www.mpiresearch.com
  • Number of Employees: 1K-5K
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

CleanBrands LLC

CleanBrands LLC is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in East Providence, RI. To find more information about CleanBrands LLC, please visit www.cleanbrands.com

H2O Plus

H2O Plus is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. H2O Plus is based in Chicago, IL. You can find more information on H2O Plus at www.h2oplus.com

Carefirst Blue Cross Blue Shield

Carefirst Blue Cross Blue Shield is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical Development International

Medical Development International is a Ponte Vedra Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BioSig Technologies

BioSig Technologies, Inc. (OTCQB: BSGM) is a medical device company that is developing a proprietary technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Minneapolis-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig`s main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and is working toward FDA 510(k) clearance for the PURE EP System.